Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04109846 · ClinicalTrials.gov registry record · NA

Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos

A NA study of Aneuploidy and Mosaicism, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT04109846 is a NA study of Aneuploidy and Mosaicism that is actively recruiting participants, run by Stanford University. The registered enrollment target is 300 participants, below the 1,398-participant average among 5 other Aneuploidy trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04109846, a NA study of Aneuploidy and Mosaicism, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.

Interventions

  • OTHER Non-euploid embryo transfer
  • OTHER Euploid Transfer

Study Locations (1)

California

  • Stanford Fertility and Reproductive Medicine Center - Sunnyvale

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-04-11
Est. Completion 2039-04-01
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04109846

The ClinicalTrials.gov registry entry for NCT04109846 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,398-participant average among 5 other Aneuploidy trials with a reported enrollment target (79% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Aneuploidy appearing as the primary indexed condition, and to 2 interventions - of which Non-euploid embryo transfer is the first listed.

NCT04109846 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04109846 about?

NCT04109846 is a clinical study titled "Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos". To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental iss...

What is the current status of trial NCT04109846?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-04-11. Estimated completion is 2039-04-01.

What conditions does trial NCT04109846 study?

This clinical trial studies the following conditions: Aneuploidy, Mosaicism, Pregnancy Outcome.

What interventions are being tested in trial NCT04109846?

The interventions under investigation include: Non-euploid embryo transfer (OTHER), Euploid Transfer (OTHER).

Who is sponsoring clinical trial NCT04109846?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04109846 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aneuploidy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.